Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1523 of 5804
-
New drug cocktail aims to shrink advanced stomach tumors
Disease control OngoingThis early phase I trial studies the effect of pembrolizumab and lenvatinib in treating patients with gastroesophageal adenocarcinoma that has spread to other places in the body (advanced/metastatic) or cannot be removed by surgery (unresectable). Immunotherapy with monoclonal an…
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New care model aims to save mothers and babies with sickle cell disease
Disease control OngoingTo implement an effective but low-cost strategy to decrease SCD maternal and perinatal mortality in Ghana. The objectives are to 1) assess the impact of a multidisciplinary SCD-obstetric team for decreasing mortality across three hospital sites in Ghana. 2) assess the implementat…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Statins take on COPD: could a heart drug curb lung Flare-Ups?
Disease control OngoingIt is a randomized, multicenter, prospective, double-blind, placebo controlled, interventional clinical trial that will be conducted in Poland, in about 12 Hospital Pulmonary Departments to evaluate the effectiveness of atorvastatin on the reduction of inflammation process in pat…
Phase: PHASE4 • Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Family dinners get a high-tech makeover to fight childhood obesity
Disease control ENROLLING_BY_INVITATIONThe proposed study is a 12-month, individual randomized controlled trial (RCT). The main aim of the study is to decrease cardiovascular disease risk (BMI percentile, neck circumference) and improve child diet quality in children ages 5-10 years old by increasing family meal quali…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
MRNA HIV vaccine trial launches in healthy volunteers
⭐️ VACCINE ⭐️ OngoingThis is an open-label, multicenter, randomized phase 1 study to evaluate the safety and immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV trimer mRNA. These trimers are based on the BG505 MD39 native-like trimer reported in Steichen et al. Immun…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:54 UTC
-
Can a 10-Session video therapy tame tantrums in kids with autism?
Symptom relief CompletedThe purpose of this research study is to evaluate a time-limited version of Parent Child Interaction Therapy (PCIT) delivered via telehealth for young children with autism spectrum disorder (ASD) and disruptive behavior problems. Families will be randomly assigned to receive 10 s…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Custom 3D-Printed ankle implant offers new hope for severe bone loss
Disease control Recruiting nowOn February 17th, 2021, the FDA officially approved the use of the first patient-specific 3D-printed talar implant for compassionate use. This is a patient-specific talar spacer designed to completely replace the talus for the treatment of talar avascular necrosis. The implant re…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Diet showdown: could paleo or keto diets ease MS symptoms?
Symptom relief OngoingThe overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of…
Phase: NA • Sponsor: Terry L. Wahls • Aim: Symptom relief
Last updated Jun 26, 2026 16:05 UTC
-
Alzheimer's drug vs. brain exercises: which works better?
Symptom relief Recruiting nowDonepezil, as well as the other symptomatic drugs of Alzheimer's disease, is not any more reimbursed by the French healthcare system, due to a controversy about its efficiency. French health authorities currently preconize a non-rug approach based on cognitive remediation or stim…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New hope for picky eaters: study tackles childhood eating disorder
Symptom relief CompletedAvoidant Restrictive Food Intake Disorder (ARFID) is a disorder that affects toddlers, children, adolescents, and adults. Individuals with ARFID are not able to consume an adequate amount or variety of food to a degree that it affects their mental and/or physical health. ARFID of…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New combo tackles brain tumors in melanoma and kidney cancer patients
Disease control TerminatedThis is a phase 2, Simon's 2-stage designed study with 2 cohorts of anti-PD-1/PD-L1 experienced patients with untreated brain metastases: 1) melanoma and 2) renal cell carcinoma (RCC).
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New 'Four-in-One' antibody takes on Hard-to-Treat blood cancers
Disease control OngoingIn this study, the safety, tolerability and preliminary effectiveness of GNC-035 in patients with relapsed/refractory hematologic malignancies will be investigated to assess the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) or maximum administered dose (MAD) for MTD …
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Brain zapping with light: a new hope for attention problems?
Symptom relief Recruiting nowInattentiveness and impulsivity in healthy adults and individuals with attention deficit hyperactivity disorder (ADHD) diminish these individuals' quality of life. Cortical hypometabolism has been hypothesized to contribute to inattentiveness in ADHD. Transcranial photobiomodulat…
Phase: NA • Sponsor: Francisco Gonzalez-Lima, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo shows promise in slowing rare sarcoma growth
Disease control CompletedMulticenter, prospective, open-labeled, 2-arm, non-comparative randomized phase II trial to assess the antitumor activity of berzosertib in association with gemcitabine
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Ear zaps might wake up coma patients?
Symptom relief CompletedNon-invasive brain stimulations techniques have recently shown promising results in patients with disorders of consciousness. Notably, a case reported improvement of level of consciousness using transcutaneous auricular vagal nerve stimulation in a patient in unresponsive wakeful…
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis phase I trial finds the best dose and side effects of cabozantinib and pamiparib in treating patients with solid tumors that have spread to other places in the body (advanced) or does not respond to treatment (refractory). Cabozantinib and pamiparib may stop the growth of tu…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for kidney cancer patients who Can't have surgery: targeted radiation trial launches
Disease control Recruiting nowThis is a multicenter, single arm phase II study of stereotactic body radiation therapy (SBRT) for patients with medically inoperable primary renal cell carcinoma (RCC).
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Supercharged immune cells take on incurable tumors
Disease control OngoingThis is a phase I/Ib study of adoptively transferred T-cell receptor gene-engineered T cells (TCR-T) targeting tumor-specific antigens, with in vivo CD40 activation and PD-1 blockade, for patients with incurable cancers. The study design is a safety lead-in TCR-T with CD40/PD-1 (…
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Spinal stimulation without tingling: a new hope for failed back surgery pain?
Disease control OngoingGiven the substantial socioeconomic impact of Spinal Cord Stimulation (SCS) implantations and given that currently no direct high-quality evidence with a relevant outcome measurement is available to guide the treatment choice between subthreshold SCS versus best medical treatment…
Phase: NA • Sponsor: Moens Maarten • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a nasal spray help Parkinson's? new trial tests insulin and glutathione combo
Disease control Recruiting nowThis study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.
Phase: PHASE2 • Sponsor: Gateway Institute for Brain Research • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC